SF
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells | JCI insight | 2024 | 31 | 31 | |||
Effects of Dalcroze eurhythmics exercise versus multicomponent exercise on physical and cognitive function, and falls in older adults : the EPHYCOS randomized controlled trial | Advanced biology | 2024 | 10 | 6 | |||
Romosozumab followed by denosumab versus denosumab only : a post hoc analysis of FRAME and FRAME extension | Journal of bone and mineral research | 2024 | 9 | 9 | |||
Fracture risk based on high-resolution peripheral quantitative computed tomography measures does not vary with age in older adults-the bone microarchitecture international consortium prospective cohort study | Journal of bone and mineral research | 2024 | 9 | 0 | |||
Maladies osseuses : ce qui a changé en 2023 | Revue médicale suisse | 2024 | 47 | 2 | |||
Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX : bone microarchitecture international consortium (BoMIC) prospective cohorts | Journal of bone and mineral research | 2024 | 9 | 6 | |||
3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate | Journal of bone and mineral research | 2024 | 48 | 19 | |||
A meta-analysis of previous falls and subsequent fracture risk in cohort studies | Osteoporosis international | 2024 | 25 | 0 | |||
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD) : Insight into Clinical Challenges in the Treatment of Type 2 Diabetes | Journal of clinical medicine | 2023 | 27 | 6 | |||
NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in mice | RMD open | 2023 | 145 | 44 | |||
Nouveaux critères de remboursement du dosage de la vitamine D : et nos patients migrants ? | Revue médicale suisse | 2023 | 33 | 7 | |||
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture | European journal of endocrinology | 2023 | 182 | 11 | |||
2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper software | Frontiers in bioengineering and biotechnology | 2023 | 52 | 40 | |||
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials | BMJ | 2023 | 32 | 7 | |||
Unusual phosphaturic mesenchymal tumor mimicking osteoid osteoma | Radiology case reports | 2023 | 83 | 43 | |||
Biochemical Markers of Bone Fragility in Patients With Diabetes | The Journal of clinical endocrinology and metabolism | 2023 | 50 | 0 | |||
A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed Tomography | Journal of bone and mineral research | 2023 | 77 | 59 | |||
The effects of time‐restricted eating and weight loss on bone metabolism and health: a 6‐month randomized controlled trial | Obesity | 2023 | 141 | 11 | |||
Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone | Nature reviews. Rheumatology | 2023 | 23 | 0 | |||
Functional brain changes in sarcopenia: evidence for differential central neural mechanisms in dynapenic older women | Aging Clinical and Experimental Research | 2023 | 91 | 31 | |||
Previous fracture and subsequent fracture risk : a meta-analysis to update FRAX | Osteoporosis international | 2023 | 31 | 7 | |||
Development of a personalized fall rate prediction model in community-dwelling older adults: a negative binomial regression modelling approach | BMC geriatrics | 2023 | 39 | 29 | |||
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism | Nutrients | 2022 | 94 | 77 | |||
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial | Osteoporosis international | 2022 | 138 | 49 | |||
Associations of Calcium Intake and Calcium from Various Sources with Blood Lipids in a Population of Older Women and Men with High Calcium Intake | Nutrients | 2022 | 110 | 57 | |||
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan | Osteoporosis international | 2022 | 161 | 0 | |||
Fracture risk following an atypical femoral fracture | Journal of bone and mineral research | 2022 | 189 | 208 | |||
Regeneration of Craniofacial Bone Induced by Periosteal Pumping | Tissue engineering. Part C, Methods. | 2022 | 158 | 2 | |||
Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk | Journal of bone and mineral research | 2022 | 256 | 282 | |||
Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fractures | Calcified tissue international | 2022 | 287 | 222 | |||
Pathophysiology of vascular calcification and bone loss: linked disorders of ageing? | Nutrients | 2021 | 168 | 99 | |||
Primary mouse osteoblast and osteoclast culturing and analysis | STAR protocols | 2021 | 317 | 153 | |||
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients | Clinical chemistry and laboratory medicine | 2021 | 234 | 97 | |||
A Novel HR-pQCT Image Registration Approach Reveals Sex-Specific Changes in Cortical Bone Retraction With Aging | Journal of Bone and Mineral Research | 2021 | 145 | 0 | |||
Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women | Osteoporosis international | 2021 | 110 | 0 | |||
Covid 19 - vitamine D - traitement de l'ostéoporose | Revue médicale suisse | 2021 | 169 | 153 | |||
Bone fragility in patients affected by congenital diseases non skeletal in origin | Orphanet Journal of Rare Diseases | 2021 | 162 | 98 | |||
Développement et évaluation des filières de l'ostéoporose en Suisse | Revue médicale suisse | 2021 | 244 | 194 | |||
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D | Nephrology Dialysis Transplantation | 2021 | 197 | 4 | |||
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review | Advances in therapy | 2021 | 120 | 141 | |||
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services | Osteoporosis international | 2021 | 186 | 88 | |||
Ostéoporose - Nouvelle molécule, nouvelles directives | Revue médicale suisse | 2021 | 72 | 24 | |||
RANKL‐Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin‐Dependent Fashion: A Potential New Mechanism of Bone Fragility | Journal of Bone and Mineral Research | 2021 | 224 | 1 | |||
Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice | Frontiers in Cell and Developmental Biology | 2021 | 152 | 64 | |||
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals | JBMR plus | 2021 | 131 | 68 | |||
Metformin: is it the well wisher of bone beyond glycemic control in diabetes mellitus? | Calcified tissue international | 2021 | 188 | 0 | |||
Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross‐sectional study | Journal of bone and mineral research | 2021 | 127 | 0 | |||
The vessels-bone axis: iliac artery calcifications, vertebral fractures and vitamin K from VIKI study | Nutrients | 2021 | 133 | 108 | |||
Short or long-term osteoporosis therapy with denosumab ? | Journal of clinical endocrinology & metabolism | 2021 | 105 | 66 | |||
Mechanically Driven Counter‐Regulation of Cortical Bone Formation in Response to Sclerostin‐Neutralizing Antibodies | Journal of Bone and Mineral Research | 2021 | 186 | 0 | |||
Reliability and validity of an adapted hip abductor strength measure as a potential new fall risk assessment for older persons: a study protocol | BMC Geriatrics | 2021 | 198 | 64 | |||
Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study | Osteoporosis international | 2021 | 76 | 0 | |||
Romosozumab : un nouveau traitement de l'ostéoporose sévère | Revue médicale suisse | 2021 | 998 | 283 | |||
Associations between age-related changes in bone microstructure and strength and dietary acid load in a cohort of community-dwelling, healthy men and postmenopausal women | The American Journal of Clinical Nutrition | 2020 | 243 | 5 | |||
A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement | Osteoporosis International | 2020 | 244 | 118 | |||
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) | Swiss Medical Weekly | 2020 | 377 | 193 | |||
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF | The Journal of clinical endocrinology and metabolism | 2020 | 103 | 98 | |||
Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk | Osteoporosis International | 2020 | 190 | 0 | |||
Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI study | Journal of Bone and Mineral Research | 2020 | 173 | 336 | |||
Ostéoporose | Revue médicale suisse | 2020 | 76 | 146 | |||
Hand grip strength and early mortality after hip fracture | Archives of Osteoporosis | 2020 | 153 | 0 | |||
Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension | Bone | 2020 | 294 | 2 | |||
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed | Bone | 2020 | 247 | 2 | |||
Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No Confidence | Journal of Bone and Mineral Research | 2020 | 238 | 5 | |||
The role of hip abductor strength in identifying older persons at risk of falls: a diagnostic accuracy study | Clinical Interventions in Aging | 2020 | 292 | 96 | |||
T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial | Journal of Bone and Mineral Research | 2020 | 231 | 62 | |||
Vitamin K and Osteoporosis | Nutrients | 2020 | 164 | 190 | |||
Fracture risk following intermission of osteoporosis therapy | Osteoporosis International | 2019 | 263 | 1 | |||
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment | Journal of Clinical Endocrinology and Metabolism | 2019 | 293 | 1 | |||
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass | Journal of Clinical Investigation | 2019 | 370 | 323 | |||
Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women | Osteoporosis International | 2019 | 260 | 1 | |||
Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study | The Lancet Diabetes & Endocrinology | 2019 | 318 | 0 | |||
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis | Osteoporosis International | 2019 | 297 | 1 | |||
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis | Advances in Therapy | 2019 | 246 | 127 | |||
Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment | Journal of Bone and Mineral Research | 2019 | 278 | 141 | |||
Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients | Osteoporosis International | 2019 | 276 | 1 | |||
Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region | Journal of Clinical Densitometry | 2019 | 233 | 141 | |||
Diabetes and fracture risk | Primer on the metabolic bone diseases and disorders of mineral metabolism | 2019 | 268 | 3 | |||
Hip muscle and hand-grip strength to differentiate between older fallers and non-fallers: a cross-sectional validity study | Clinical Interventions in Aging | 2018 | 523 | 208 | |||
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension | Journal of Bone and Mineral Research | 2018 | 402 | 1 | |||
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome | Journal of Bone and Mineral Research | 2018 | 390 | 0 | |||
Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women | Journal of Bone and Mineral Research | 2018 | 572 | 0 | |||
Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women | Osteoporosis International | 2018 | 415 | 6 | |||
β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice | American Journal of Physiology. Endocrinology and Metabolism | 2018 | 360 | 4 | |||
Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure | Osteoporosis International | 2018 | 546 | 1 | |||
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab | Journal of Bone and Mineral Research | 2018 | 374 | 0 | |||
Osteoporosis: Romosozumab to rebuild the foundations of bone strength | Nature Reviews Rheumatology | 2018 | 421 | 0 | |||
Ostéoporose | Revue médicale suisse | 2018 | 292 | 2 | |||
Phosphate wasting disorders in adults | Osteoporosis International | 2018 | 378 | 1 | |||
Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study | Frontiers in Pharmacology | 2018 | 467 | 196 | |||
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice | Bone | 2018 | 375 | 2 | |||
Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective Study | Journal of Bone and Mineral Research | 2018 | 487 | 3 | |||
Ostéoporose chez l'insuffisant rénal: quelle évaluation et quel traitement? Place de la biopsie osseuse | Revue médicale suisse | 2018 | 346 | 1 | |||
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis | Calcified Tissue International | 2018 | 335 | 0 | |||
Prevention of fractures in patients with osteoporosis | The Lancet | 2018 | 429 | 1 | |||
Intra-rater reliability of hip abductor isometric strength testing in a standing position in older fallers and non-fallers | European Review of Aging and Physical Activity | 2018 | 415 | 169 | |||
Ostéoporose | Revue médicale suisse | 2018 | 378 | 100 | |||
Diagnosis and management of bone fragility in diabetes: an emerging challenge | Osteoporosis International | 2018 | 362 | 196 | |||
Les métamorphoses du traitement de l'ostéoporose | Revue médicale suisse | 2017 | 355 | 14 | |||
Evaluation of hip abductor and adductor strength in the elderly: a reliability study | European review on aging and physical activity | 2017 | 454 | 202 | |||
Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX | Journal of Bone and Mineral Research | 2017 | 487 | 0 | |||
Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical Bone | Calcified Tissue International | 2017 | 483 | 1 | |||
Cathepsin K Controls Cortical Bone Formation by Degrading Periostin | Journal of Bone and Mineral Research | 2017 | 425 | 1 | |||
IOF Compendium of Osteoporosis | 2017 | 1 018 | 394 | ||||
Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal women | The American journal of clinical nutrition | 2017 | 589 | 3 | |||
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study | BMC musculoskeletal disorders | 2017 | 450 | 191 | |||
Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates | Osteoporosis International | 2017 | 464 | 2 | |||
Mechanisms of diabetes mellitus-induced bone fragility | Nature reviews. Endocrinology | 2017 | 471 | 0 | |||
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO | Swiss Medical Weekly | 2017 | 421 | 202 | |||
Prepubertal Impact of Protein Intake and Physical Activity on Weight-Bearing Peak Bone Mass and Strength in Males | The Journal of clinical endocrinology and metabolism | 2017 | 492 | 0 | |||
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) | Inflammatory Bowel Diseases | 2017 | 523 | 1 | |||
Traitement médicamenteux de l'ostéoporose: durée et procédure après la fin du traitement | Swiss Medical Forum | 2017 | 343 | 1 | |||
Diabetes and Bone | Calcified tissue international | 2017 | 416 | 1 | |||
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting | Osteoporosis International | 2017 | 422 | 0 | |||
hypophosphatasie de l'adulte | Revue médicale suisse | 2017 | 446 | 6 | |||
Jusqu'où et jusqu'à quand traiter l'ostéoporose? | Revue médicale suisse | 2017 | 366 | 97 | |||
Fracture Prospectively Recorded From Prepuberty to Young Adulthood: Are They Markers of Peak Bone Mass and Strength in Males? | Journal of Bone and Mineral Research | 2017 | 467 | 0 | |||
Within and across-sex inheritance of bone microarchitecture | The Journal of clinical endocrinology and metabolism | 2017 | 1 478 | 10 | |||
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis | Therapeutic advances in musculoskeletal disease | 2016 | 487 | 0 | |||
Le traitement séquentiel présente des avantages | Leading Opinions. Médecine Interne | 2016 | 359 | 1 | |||
Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses | BoneKEy Reports | 2016 | 358 | 145 | |||
Traitement de l'ostéoporose : quel médicament et pour qui? | La gazette médicale - info@gériatrie | 2016 | 472 | 678 | |||
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice | Calcified tissue international | 2016 | 534 | 3 | |||
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees | Journal of bone and mineral research | 2016 | 559 | 7 | |||
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | Osteoporosis international | 2016 | 433 | 0 | |||
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture | Archives of osteoporosis | 2016 | 461 | 200 | |||
Periostin action in bone | Molecular and cellular endocrinology | 2016 | 376 | 0 | |||
Mechanisms in Endrocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus | European journal of endocrinology | 2016 | 423 | 1 | |||
Occupation-dependent loading increases bone strength in men | Osteoporosis international | 2016 | 623 | 3 | |||
Romosozumab Treatment in Postmenopausal Women with Osteoporosis | The New England journal of medicine | 2016 | 795 | 1 243 | |||
Santé osseuse des retraités genevois | Revue médicale suisse | 2015 | 478 | 2 | |||
Gene–Diet Interactions on Bone | Nutrition and Bone Health | 2015 | 619 | 1 | |||
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years | Osteoporosis international | 2015 | 481 | 0 | |||
Periostin expression contributes to cortical bone loss during unloading | Bone | 2015 | 517 | 1 | |||
Calcinose cutanée associée aux connectivites | Revue médicale suisse | 2015 | 999 | 3 | |||
Taxonomy of rare genetic metabolic bone disorders | Osteoporosis international | 2015 | 516 | 0 | |||
Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure | The Journal of clinical endocrinology and metabolism | 2015 | 574 | 0 | |||
Sauvons l'ostéoporose | Revue médicale suisse |